Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Assessment Development
9%
Blood Loss
18%
Bolus
18%
Carbetocin
36%
Carboprost
18%
Cesarean Delivery
100%
Clinically Insignificant
9%
Cochrane Central Register of Controlled Trials
9%
Confidence Interval
18%
Development Tools
9%
Embase
9%
Ergometrine
45%
Estimated Blood Loss
27%
Evaluation Assessment
9%
Evaluation Tool
9%
Grading of Recommendations
9%
High Probability
9%
Loss Networks
9%
Maternal Death
9%
MEDLINE
9%
Meta-analysis
9%
Meta-analysis Approach
9%
Misoprostol
45%
Nausea
9%
Network Meta-analysis
100%
Oxytocin
100%
Oxytocin Administration
18%
Pharmacologic Agents
100%
Placebo
9%
Postpartum Hemorrhage
100%
Randomized Controlled Trial
18%
Recommendation Tools
9%
Reporting Item
9%
Sensitivity Analysis
9%
Summary of Findings Table
9%
Surface under the Cumulative Ranking Curve
9%
Surgical Environment
9%
Systematic Meta-analysis
9%
Treatment Effect
9%
Uterotonics
63%
World Health Organization
9%
Nursing and Health Professions
Bleeding
41%
Carbetocin
33%
Carboprost
16%
Cesarean Section
100%
Cochrane Library
8%
Confidence Interval
16%
Embase
8%
Ergometrine
33%
Ergometrine Plus Oxytocin
8%
Maternal Death
8%
Meta Analysis
8%
Misoprostol
41%
Nausea
8%
Network Meta-Analysis
100%
Oxytocin
100%
Placebo
8%
Postpartum Hemorrhage
100%
Practice Guideline
8%
Systematic Review
16%
World Health Organization
8%
Medicine and Dentistry
Bleeding
41%
Carbetocin
33%
Carboprost
16%
Cesarean Section
100%
Ergometrine
33%
Ergometrine Plus Oxytocin
8%
Lochia
100%
Maternal Death
8%
Meta-Analysis
8%
Misoprostol
41%
Nausea
8%
Network Meta-Analysis
100%
Oxytocin
100%
Placebo
8%
Primary Outcome
16%
Randomized Controlled Trial
16%
Systematic Review
16%
Treatment Effect
8%
Pharmacology, Toxicology and Pharmaceutical Science
Bleeding
41%
Carbetocin
33%
Carboprost
16%
Ergometrine
33%
Ergometrine Plus Oxytocin
8%
Maternal Death
8%
Misoprostol
41%
Nausea
8%
Oxytocin
100%
Placebo
8%
Postpartum Hemorrhage
100%
Randomized Controlled Trial
16%